Skip to main content
. 2016 May 12;4(6):E665–E672. doi: 10.1055/s-0042-105869

Table 2. Correlation of clinicopathological characteristics of currently H. pylori – negative gastric cancers with NBI-ME appearance.

NBI-ME appearance
Characteristic Gastritis-like (64 lesions) Conspicuous (130 lesions) P value
History of eradication therapy: positive/negative 42/22  57/73 0.006
Endoscopic extent of atrophy: mild, moderate/severe1 50/14  55/75  < 0.001
Size: ≤ 10 mm/ > 10 mm 29/35  55/75 0.758
Location:
 upper, middle/lower 43/21  67/63 0.046
 less/gre, ant, post 34/30  65/65 0.760
Macroscopic type: elevated/depressed 22/42  42/88 0.871
Histological type, predominant: tub1 (low)/tub1 (high), tub2 51/13  68/62  < 0.001
Depth of invasion: mucosa/submucosa 58/6 117/13 1.000
Surface differentiation: positive/negative 39/25  15/115  < 0.001
Non-neoplastic epithelium: positive/negative 26/38  17/113  < 0.001
Histological grade of atrophy: normal, mild, moderate/marked2 38/26  47/83 0.003
Histological grade of intestinal metaplasia: normal, mild, moderate/marked2 58/6  77/53  < 0.001

NBI-ME, narrow-band imaging with magnified endoscopy; less/gre, ant, post, lesser/greater curvature, anterior or posterior wall; tub1 (low/high), well-differentiated tubular adenocarcinoma, low/high grade atypia; tub2, moderately differentiated tubular adenocarcinoma.

1

Endoscopic extent of atrophy was determined according to the Kimura-Takemoto classification 18: mild, closed-1, closed-2; moderate, closed-3, open-1; severe, open-2, open-3.

2

Histological grades of atrophy and intestinal metaplasia were evaluated in the surrounding mucosa adjacent to the cancer according to the updated Sydney system 26.